Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice ; volume:25 ; number:9 ; day:5 ; month:6 ; year:2023 ; pages:965-977 ; date:9.2023
Current oncology reports ; 25, Heft 9 (5.6.2023), 965-977, 9.2023
- Creator
-
Kim, Janice
Freeman, Kendall
Ayala, Alyssa
Mullen, McKay
Sun, Zijie
Rhee, June-Wha
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11912-023-01424-2
- URN
-
urn:nbn:de:101:1-2023111116441559079397
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Janice
- Freeman, Kendall
- Ayala, Alyssa
- Mullen, McKay
- Sun, Zijie
- Rhee, June-Wha
- SpringerLink (Online service)
Other Objects (12)
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Basic biology
Androgen deprivation modulates the inflammatory response induced by irradiation
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer
Cardiovascular toxicities of androgen deprivation therapy in Asian men with localized prostate cancer after curative radiotherapy: a registry-based observational study
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Basic biology
Androgen deprivation modulates the inflammatory response induced by irradiation
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer
Cardiovascular toxicities of androgen deprivation therapy in Asian men with localized prostate cancer after curative radiotherapy: a registry-based observational study
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Basic biology
Androgen deprivation modulates the inflammatory response induced by irradiation
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer